4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... SGLT2i in HF and CKD ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #Management #Cardiology
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... therapies" for HFrEF ... used in HFrEF: ... #CKD #HFrEF #management ... #pharmacology #cardiology
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... guidelines for CAD ... and HFpEF* 2. ... #HFpEF #CAD #Management ... #Algorithm #cardiology